1. Home
  2. Analysis
  3. Treprostinil
  4. Midazolam

Treprostinil and Midazolam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Treprostinil (treprostinil) and Midazolam (midazolam). Common drug interactions include cardiac arrest among females.

The phase IV clinical study analyzes what interactions people have when they take Treprostinil and Midazolam. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Treprostinil?

Treprostinil has active ingredients of treprostinil. eHealthMe is studying from 7,695 Treprostinil users. Check the latest studies of Treprostinil.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

On Jul, 13, 2026

16 people who take Treprostinil and Midazolam together, and have interactions are studied.

Treprostinil and Midazolam drug interactions.

What are the common drug interactions of Treprostinil and Midazolam, by gender? *:

female:

  1. Cardiac arrest
  2. Drug ineffective
  3. Cerebral haemorrhage (bleeding within the brain)
  4. Anaphylactic reaction (serious allergic reaction)
  5. Cardiac perforation (a hole in heart)
  6. Haematoma (collection of blood outside the blood vessels)
  7. Maternal exposure during delivery (use of substance during pregnancy)
  8. Maternal exposure during pregnancy (use of substance during pregnancy)
  9. Premature delivery

male:

n/a

What are the common drug interactions of Treprostinil and Midazolam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Cardiac arrest
  2. Drug ineffective
  3. Cerebral haemorrhage (bleeding within the brain)
  4. Anaphylactic reaction (serious allergic reaction)
  5. Cardiac perforation (a hole in heart)
  6. Haematoma (collection of blood outside the blood vessels)

10-19:

n/a

20-29:

  1. Maternal exposure during delivery (use of substance during pregnancy)
  2. Maternal exposure during pregnancy (use of substance during pregnancy)
  3. Premature delivery

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 13 people, 81.25%
  2. Stress And Anxiety: 2 people, 12.50%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 6.25%
  4. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 6.25%
  5. Epidural Anaesthesia: 1 person, 6.25%
  6. Decreased Ventricular Afterload (decreased tension or stress developed in the wall of the left ventricle during ejection): 1 person, 6.25%
  7. Anaesthesia: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Treprostinil and Midazolam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Treprostinil and Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Treprostinil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Treprostinil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Midazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on treprostinil and midazolam (the active ingredients of Treprostinil and Midazolam, respectively), and Treprostinil and Midazolam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.